 thromboxan develop genet hypertens lyon rat strain renal biosynthesi thromboxan young hypertens rat lyon strain develop hypertens lyon hypertens femal rat thromboxan synthetas inhibitor dazmegrel oki thromboxan receptor antagonist AH prehypertens stage treatment week age dazmegrel systol blood pressur week age dazmegrel oki similar progress specif reduct urinari excret thromboxan transient decreas blood pressur level dazmegrel last blood pressure-low effect oki schedul blood pressur level effect week cessat treatment interestingli activ dose thromboxan synthetas inhibitor thromboxan receptor blocker delay antihypertens properti elev product thromboxan young lyon hypertens rat like blood pressur regul effect independ direct vasoconstrictor properti